ProtoKinetix's AAGP(TM) Preserves 100% Viable Stem Cells.VANCOUVER, British Columbia -- ProtoKinetix, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :PKTX) announced the latest cryopreservation cryopreservation /cryo·pres·er·va·tion/ (-prez?er-va´shun) maintenance of the viability of excised tissue or organs by storing at very low temperatures. cry·o·pres·er·va·tion n. results using mouse embryonic stem cells preserved at -80xC for 2 days and rapidly thawed to assay for viability. PKTX is currently in discussion with several corporations and Research Institutes about the commercialization of AAGP AAGP American Association of Grant Professionals AAGP American Association of Geriatric Psychiatry AAGP American Academy of General Practice AAGP Aerobic Attached Growth Process AAGP Aeromedical Airlift Group AAGP Acoustic Analysis Guidance Product [TM] in the application of cryopreservation of cell lines and we are pleased to report the following results: Based on previous experiments using stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , concentrations of AAGP[TM] were varied to obtain the lowest and most optimal concentrations. < < i.) < control - 10% Dimethyl Sulfoxide (DMSO) 66% viability < < ii.) < 1mg/ml of AAGPTM 1-J +10% DMSO 89% viability < < iii.) < 5mg/ml of AAGPTM 1-J + 10% DMSO 96% viability < < iv.) < 4.4mg/ml of AAGPTM 5-F + 10% DMSO 100% viability These experiments clearly demonstrate that AAGP[TM] concentrations can be lowered while maintaining close to the full potential of the molecule with regards to cryopreservation. These results confirm a substantial benefit in the preservation of expensive cell lines and tissue, clearly meeting a need in research, industry and medicine. About ProtoKinetix: ProtoKinetix, Inc. is a Biotechnical Company dedicated to the development of a family of synthetic antifreeze antifreeze, substance added to a solvent to lower its freezing point. The solution formed is called an antifreeze mixture. Antifreeze is typically added to water in the cooling system of an internal-combustion engine so that it may be cooled below the freezing point glycoproteins (AAGP[TM]) for human and veterinary medicine veterinary medicine, diagnosis and treatment of diseases of animals. An early interest in animal diseases is found in ancient Greek writings on medicine. Veterinary medicine began to achieve the stature of a science with the organization of the first school in the and the biotechnology and cosmetic industries. Using previously published research on native antifreeze proteins and antifreeze glycoproteins as a guide, and coordinating a vast pool of world-recognized intellectual talent in a networked environment, PKTX is conducting rapid and meaningful research with a view to developing markets for this very useful family of molecules. Sign up for free automatic email news alerts at our new website at: www.protokinetix.com The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " for forward-looking statements. Some information included in this press release contains statements that are forward looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion